Drug-labels.com

Valsartan (Actavis Pharma): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
40 mg, 160 mg, 80 mg, 320 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Valsartan (Actavis Pharma)

ABOUT THIS MEDICATION

What the medication is used for:

High blood pressure (hypertension):

VALSARTAN lowers high blood pressure.

What it does:

VALSARTAN is an angiotensin receptor blocker (ARB). You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking VALSARTAN regularly even if you feel fine.

When it should not be used:

Do not take VALSARTAN if you:

  • Are allergic to valsartan or to any non-medicinal

    ingredient in the formulation.

  • Have experienced an allergic reaction (angioedema) with

    swelling of the hands, feet, or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing, to any ARB. Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.

  • Are taking a medicine that contains aliskiren (such as

    Rasilez) and you have diabetes or kidney disease.

  • Are pregnant or intend to become pregnant. Taking

    VALSARTAN during pregnancy can cause injury and even death to your baby.

  • Are breastfeeding. It is possible that VALSARTAN

    passes into breast milk.

What the medicinal ingredient is:

Valsartan

What the nonmedicinal ingredients are:

VALSARTAN also contains the following non-medicinal ingredients:

40 mg tablets: Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, sodium dodecyl sulphate, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide, and iron oxide yellow.

80 mg tablets: Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, sodium dodecyl sulphate, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide, iron oxide red, FD&C Yellow #6, and FD&C Blue #2.

160 mg tablets: Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, sodium dodecyl sulphate, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide, iron oxide yellow, and FD&C Yellow #6.

320 mg tablets: Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, sodium dodecyl sulphate, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide, iron oxide black, iron oxide red, iron oxide yellow, FD&C Red #40, and FD&C Blue #2.

If you are on a special diet, or if you are allergic to any substance, ask your doctor or pharmacist whether any of these ingredients may cause a problem.

What dosage forms it comes in:

VALSARTAN is available in four tablet strengths containing valsartan 40 mg, 80 mg, 160 mg and 320 mg.

  • VALSARTAN 40 mg tablets are yellow, film-coated, oval-shaped, biconvex tablet with “V” bisect “S” on one side and “ ” on the other side.
  • VALSARTAN 80 mg tablets are pink, film-coated, round, biconvex tablet with “VS” over “80” on one side and “ ” on the other side.
  • VALSARTAN 160 mg tablets are orange, film-coated, oval-shaped, biconvex tablet with “VS 160” on one side and “ ” on the other side.
  • VALSARTAN 320 mg tablets are dark grey-violet, film-coated, oval-shaped, biconvex tablet with “VS 320” on one side and “ ” on the other side.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions - Pregnancy VALSARTAN should not be used during pregnancy. If you discover that you are pregnant while taking VALSARTAN, stop the medication and contact your doctor, nurse or pharmacist as soon as possible.

BEFORE you use VALSARTAN talk to your doctor, nurse or pharmacist if you:

  • Have experienced an allergic reaction to any drug, including drugs used to lower blood pressure, such as angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB).
  • Have narrowing of an artery or a heart valve.
  • Have had a heart attack or stroke.
  • Have heart failure.
  • Have diabetes, liver or kidney disease.
  • Are on dialysis
  • Are dehydrated or suffer from excessive vomiting,

    diarrhea, or sweating.

  • Are taking a salt substitute that contains potassium,

    potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).

  • Are on a low-salt diet.
  • Are taking a medicine that contains aliskiren, such as

    Rasilez, used to lower high blood pressure. The combination with VALSARTAN is not recommended.

  • Are taking an angiotensin converting enzyme (ACE)

    inhibitor.

  • Are less than 18 years old.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to VALSARTAN. Dizziness, light headedness, or fainting can especially occur after the first dose and when the dose is increased.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with VALSARTAN:

  • Agents increasing serum potassium, such as a salt

    substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill”).

  • Lithium, a medicine used to treat some types of

    psychiatric illness such as bipolar disease.

  • Non-steroidal anti-inflammatory drugs (NSAIDs), used

    to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.

  • Other blood pressure lowering drugs, including diuretics

    (“water pills”), ACE inhibitors or aliskiren.

  • Rifampin an antibiotic.
  • Cyclosporine a drug used to protect against transplant

    rejection.

  • Ritonavir a antiretroviral drug used to treat HIV/AIDS

    infection.

PROPER USE OF THIS MEDICATION

Take VALSARTAN exactly as prescribed. Swallow VALSARTAN tablets with a glass of water. It is recommended to take your dose at about the same time everyday preferably in the morning. You can take VALSARTAN with or without food, but it should be taken the same way each day. Do not exceed the

recommended dose.

Usual Adult Dose:

High blood pressure (hypertension):

Recommended Initial dose: 80 mg once a day. Dose should be increased gradually.

Maximum dose: 320 mg a day

Overdose:

If you think you have taken too much VALSARTAN contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • Dizziness, Light headedness,
  • Drowsiness,
  • Rash,
  • Diarrhea, vomiting, nausea,
  • Headache
  • Back or leg pain, muscle cramps,
  • Muscle pain, muscle weakness,
  • Unusual tiredness, weakness,
  • Cough,
  • Impotence,
  • Nose bleed
  • Blistering skin (sign of dermatitis bullous)

If any of these affects you severely, tell your doctor, nurse or pharmacist.

VALSARTAN can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN

AND WHAT TO DO ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and seek

immediate medical help

Only if

severe

In all cases
Common

Allergic reactions:

Skin rash, skin

eruption or other effect on the skin or eyes

√

Increased levels of potassium in the blood: Irregular heartbeats, muscle weakness and

generally feeling unwell

√
Uncommon

Low blood

pressure

(hypotension):

Dizziness, fainting, light headedness may occur when you go from lying or sitting to standing up

√

Angioedema/

Allergic reactions:

Rash, hives,

swelling of the lips, face or neck, tongue or throat

accompanied by difficulty in

breathing,

swallowing or

speaking

√

Kidney Disorder: Change in

frequency of

urination, nausea, vomiting, swelling of the extremities, fatigue

√

Liver Disorder:

Yellowing of the skin or eyes, dark urine, abdominal pain, nausea,

vomiting, loss of appetite

√

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN

AND WHAT TO DO ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and seek immediate medical help

Only if

severe

In all cases
UncommonRhabdomyolysis: Muscle pain that you cannot explain, muscle tenderness or weakness, dark brown urine√
Abdominal pain√

Cardiac failure:

Breathlessness, difficulty

breathing when lying down,

swelling of the feet or legs

√

Vasculitis:

Inflammation of blood vessels

purplish-red spots, fever, itching

√

Decreased

Platelets: Bruising, unusual bleeding, fatigue and

weakness

√

Anemia: Fatigue, loss of energy,

weakness, shortness of breath

√

Decreased white blood cells:

Infections, fatigue, fever, aches, pains, and flu-like

symptoms, sore throat or mouth ulcers

√
Insomnia√

Flu like symptoms, joint pain,

pharyngitis,

inflammation of sinuses, runny or stuffy nose, swollen hands, ankles or feet, upper

respiratory tract infection, viral infection

√

Palpitations:

Irregular heartbeats

√

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN

AND WHAT TO DO ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and seek

immediate medical help

Only if

severe

In all cases
UnknownChange in libido√

Blistering skin

reactions with

symptoms such as rash, red skin,

blistering of the lips, eyes or mouth, skin peeling and fever

√

This is not a complete list of side effects. For any unexpected effects while taking VALSARTAN, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

Do not use VALSARTAN past the expiry date shown on the pack.

Store your VALSARTAN tablets at room temperature, between 15°C to 30°C. Protect from heat and moisture.

Keep this medicine out of the reach and sight of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

----------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines

are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

----------------------------------------------------------------------------

NOTE: Should you require information related to the
management of the side effect, please contact your health
care provider before notifying Canada Vigilance. The
Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

Please consult your doctor or pharmacist with any questions or concerns you may have regarding your individual condition.

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Actavis Pharma Company, at: 1-866-254-6111

Actavis Pharma Company

6733 Mississauga Road, Suite 400

Mississauga, ON

Canada, L5N 6J5

Last revised: November 6, 2014

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02433923

Revision date stated in the text: November 6, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Valsartan (Actavis Pharma)

Rx or OTC
Prescription (Rx)?
DIN 02433923, 02433990, 02433982, 02434008
Schedule(s) PRESCRIPTION
Active ingredient(s) Valsartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA03 Valsartan
Company ACTAVIS PHARMA COMPANY
Current status Cancelled Pre Market
Current status date September 1, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02433923 40 MG Tablet Cancelled Pre Market September 1, 2017
02433990 160 MG Tablet Cancelled Pre Market September 1, 2017
02433982 80 MG Tablet Cancelled Pre Market September 1, 2017
02434008 320 MG Tablet Cancelled Pre Market September 1, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.